Allergan Strengthens its Ophthalmology Pipeline with US$1.5 B Alliance with Molecular Partners
By Heather Cartwright
PharmaDeals Review: Vol 2012 Issue 9 (Table of Contents)
Published: 4 Sep-2012
DOI: 10.3833/pdr.v2012.i9.1797 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Allergan has further endorsed Molecular Partners’ DARPin® platform by signing two separate agreements with the company, together worth approximately US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: PharmaDeals Ltd
RSS